A Patient-Level Meta-Analysis of Intensive Glucose Control in Critically Ill Adults
Derick Adigbli,Yang Li,Naomi Hammond,Richard Chatoor,Anthony G Devaux,Qiang Li,Laurent Billot,Djillali Annane,Yaseen Arabi,Federico Bilotta,Julien Bohé,Frank Martin Brunkhorst,Alexandre Biasi Cavalcanti,Deborah Cook,Christoph Engel,Deborah Green-LaRoche,Wei He,William Henderson,Cornelia Hoedemaekers,Gaetano Iapichino,Pierre Kalfon,Gisela de La Rosa,Afsaneh Lahooti,Iain Mackenzie,Sajeev Mahendran,Christian Mélot,Imogen Mitchell,Tuomas Oksanen,Federico Polli,Jean-Charles Preiser,Francisco Garcia Soriano,Ruan Vlok,Lingcong Wang,Yuan Xu,Anthony P Delaney,Gian Luca Di Tanna,Simon Finfer
DOI: https://doi.org/10.1056/EVIDoa2400082
Abstract:Background: Whether intensive glucose control reduces mortality in critically ill patients remains uncertain. Patient-level meta-analyses can provide more precise estimates of treatment effects than are currently available. Methods: We pooled individual patient data from randomized trials investigating intensive glucose control in critically ill adults. The primary outcome was in-hospital mortality. Secondary outcomes included survival to 90 days and time to live cessation of treatment with vasopressors or inotropes, mechanical ventilation, and newly commenced renal replacement. Severe hypoglycemia was a safety outcome. Results: Of 38 eligible trials (n=29,537 participants), 20 (n=14,171 participants) provided individual patient data including in-hospital mortality status for 7059 and 7049 participants allocated to intensive and conventional glucose control, respectively. Of these 1930 (27.3%) and 1891 (26.8%) individuals assigned to intensive and conventional control, respectively, died (risk ratio, 1.02; 95% confidence interval [CI], 0.96 to 1.07; P=0.52; moderate certainty). There was no apparent heterogeneity of treatment effect on in-hospital mortality in any examined subgroups. Intensive glucose control increased the risk of severe hypoglycemia (risk ratio, 3.38; 95% CI, 2.99 to 3.83; P<0.0001). Conclusions: Intensive glucose control was not associated with reduced mortality risk but increased the risk of severe hypoglycemia. We did not identify a subgroup of patients in whom intensive glucose control was beneficial. (Funded by the Australian National Health and Medical Research Council and others; PROSPERO number CRD42021278869.).